Article Text

Download PDFPDF

Inducible nitric oxide and pulmonary infection
Free
  1. SUVEER SINGH,
  2. S JOHN WORT,
  3. TIMOTHY W EVANS
  1. Unit of Critical Care
  2. Imperial College School of Medicine
  3. Royal Brompton Hospital
  4. London SW3 6NP
  5. UK
  1. Professor T W Evans.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Nitric oxide (NO) is an endogenously produced vasodilator which modulates systemic and pulmonary blood flow through the actions of cyclic guanylate monophosphate (cGMP) on vascular smooth muscle.1-4 Non-haemodynamic properties of NO include the modulation of platelet inhibition, neurotransmission, hormone release, and cell growth. Under physiological circumstances the basal production of NO is regulated by constitutive forms of the enzyme NO synthase (cNOS). Under conditions of chemical and mechanical stress increased NO production is detectable, produced primarily via an inducible NOS isoform (iNOS).5 ,6

Evidence has accumulated that NO is implicated in the pathogenesis of sepsis and septic shock and may contribute to the development of multiple organ dysfunction. Firstly, iNOS has been isolated from human neutrophils in urinary sepsis7 and from alveolar macrophages in sepsis induced acute lung injury (ALI).8Secondly, NO is known to influence the inflammatory response through actions on both innate and adaptive immune systems.9Thirdly, non-specific cNOS and iNOS inhibition using novel …

View Full Text